HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigitte Wieles Selected Research

HA-1 antigen

3/2009Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigitte Wieles Research Topics

Disease

3Neoplasms (Cancer)
10/2012 - 02/2004
2Graft vs Host Disease (Graft-Versus-Host Disease)
03/2009 - 05/2005
2Leukemia
10/2005 - 05/2005
2Tuberculosis (Tuberculoses)
09/2005 - 05/2002
1Hematologic Neoplasms (Hematological Malignancy)
10/2005
1Multibacillary Leprosy
09/2005
1Leprosy (Hansen's Disease)
09/2005
1Infections
09/2005
1Paucibacillary Leprosy
09/2005

Drug/Important Bio-Agent (IBA)

3Minor Histocompatibility AntigensIBA
03/2009 - 05/2005
3AntigensIBA
09/2005 - 05/2002
2Peptides (Polypeptides)IBA
10/2005 - 02/2004
1VaccinesIBA
10/2012
1HA-1 antigenIBA
03/2009
1DecitabineFDA Link
03/2009
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2009
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
10/2005
1Interferon-gamma (Interferon, gamma)IBA
09/2005
1Recombinant ProteinsIBA
09/2005
1Proteins (Proteins, Gene)FDA Link
02/2004

Therapy/Procedure

4Stem Cell Transplantation
03/2009 - 02/2004
3Immunotherapy
03/2009 - 02/2004
1Therapeutics
10/2012